(Total Views: 490)
Posted On: 09/19/2022 8:32:52 AM
Post# of 148870
I was wrong - it will be Wed, 28th. It's incouraging they want to have it mid-week instead of after the close on Friday.
CytoDyn to Hold Webcast to Provide a Quarterly Company Update
VANCOUVER, Washington, Sept. 19, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"
, a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Kelly, Chief Medical Officer and Head of Business Development, will host an investment community webcast to provide a quarterly Company update on Wednesday, September 28, 2022.
https://www.cytodyn.com/newsroom/press-releas...ly-company
CytoDyn to Hold Webcast to Provide a Quarterly Company Update
VANCOUVER, Washington, Sept. 19, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"
, a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Kelly, Chief Medical Officer and Head of Business Development, will host an investment community webcast to provide a quarterly Company update on Wednesday, September 28, 2022. https://www.cytodyn.com/newsroom/press-releas...ly-company
(2)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼
